‘ALT Focused Therapy’: A new approach to manage chronic liver diseases
The number of deaths caused by liver cancer is constantly increasing; in 2012, liver cancer has caused more deaths than any other cancers globally. The prevalence and severity liver disease is obvious. To liver disease patients, nothing is more worrying than chronic inflammation and the possibility of developing more serious liver diseases.
To change the situation and treat liver disease more effectively, other than developing new medicine, reinforcing protection work and maintaining a healthy lifestyle, we should also understand the weaknesses of the current treatment and make adjustments accordingly. Let’s look at the illustration below:
We can see that the treatment process now aims to eliminate the cause of liver damage first (e.g. Hepatitis virus, fat, alcohol, etc.). Then, the liver’s self-repair ability allows liver cells to recover normal liver function to resume. The biggest problem and weakness of this approach is the long period of liver cell injury (the red bar). In addition, the success rate of most drugs is low while the cost is high; not to mention the long treatment time and severe side effects. In other words, the current treatment approach lacks focus on the recovery process. Chronic liver injury causes liver fibrosis, cirrhosis and increases the risk of liver cancer greatly.
In view of this, chronic liver disease patients should focus on enhancing liver cell recovery and shortening the time with liver damage. We therefore suggest ‘ALT Focused Therapy’:
The major advantage of ‘ALT Focused Therapy’ is that the most urgent and dangerous problem is tackled first. By first stopping long term injury to liver cells, liver fibrosis and cirrhosis can be prevented, and the chance of liver cancer can be reduced. After liver function is improved, patients can then carry out drug treatment to eliminate the harmful substances in their body gradually. When compared with the current approach, ‘ALT Focused Therapy’ can help patients greatly reduce the time with liver injury (the red bar is shortened significantly).
To carry out ALT Focused Therapy, YHK is a safe and effective formula that can help liver cell recovery. Clinical Research shows that YHK can effectively normalise ALT level and improve liver health quickly (within 10-30 days). It is an ideal options for liver patients who wish to quickly repair their liver cells and improve liver function.
- The number of liver cancer rising to all time high. http://www.cancer.gov/research/progress/annual-report-nation?utm_content=sf45009370&utm_medium=spredfast&utm_source=facebook&utm_campaign=National+Cancer+Institute&cid=fb_NCIMain_nci_liver.arn16_sf45009370#mortalityhighlights (Accessed: 2016-06-14)
- YHK have clear effect in lowering ALT & AST https://www.kyotsujigyo.net/document/yhk/10_clincial.pdf (Accessed: 2015-12-10)
- * All research and clinical data should be used as reference purposes only, results may vary.